Delivery Order SPE2DR25D3301-SPE2DR26F18VF
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Zolmitriptan 2.5 mg orally disintegrating tablets in unit dose packaging (6-count format) under a firm fixed-price contract valued at $11,572.48. The award was made on November 10, 2025, with an ultimate completion date of November 12, 2025, and is classified as a non-set-aside, competitively awarded delivery order. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania serves as both the place...
- The Defense Logistics Agency awarded a $1,281.12 firm fixed-price delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of Zolmitriptan 2.5 mg orally disintegrating tablets in unit dose packaging (6-count). The contract is non-set-aside and competitively awarded, with a completion date of June 3, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, is the prime contractor on this delivery order, which falls...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 21, 2025, for the supply of Zolmitriptan 5 mg orally disintegrating tablets in unit dose packaging. This competitive award, valued at $1,613.03 with a firm fixed price structure, represents a single delivery order without set-aside designation. The contract is scheduled for completion on October 22, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,058.12 to AmerisourceBergen Drug Corp for the supply of Zolmitriptan 5 mg orally disintegrating tablets in unit dose packaging. This competitive award, issued on November 26, 2025, with completion targeted for November 28, 2025, employs firm fixed pricing with no set-aside designation. The pharmaceutical will be delivered to Conshohocken, Pennsylvania, the location of AmerisourceBergen's corporate office and headquarters....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 14, 2025, for the supply of Zolmitriptan 5 mg orally disintegrating tablets in unit dose packaging. This competitively awarded, non-set-aside contract carries a ceiling value of $1,069.34 and is classified as a firm fixed price delivery order with an ultimate completion date of November 17, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this work at its...
- The Defense Logistics Agency awarded a delivery order valued at $9,306.66 to AmerisourceBergen Drug Corp for Zolmitriptan 5mg ODT (orally disintegrating tablets) in quantities of 3 units. The award, issued on November 26, 2025, with a completion date of December 24, 2025, utilizes firm fixed-price pricing and carries no set-aside designation, indicating it was competitively awarded. The product will be delivered to the contractor's location in Conshohocken, Pennsylvania, which serves as the...
- The Defense Logistics Agency awarded a $8,776.11 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Zolmitriptan 2.5 mg orally disintegrating tablets in unit dose packaging (six count). The contract, which was competitively awarded with no set-aside designation, is scheduled for completion by December 12, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $18,142.31 delivery order to AmerisourceBergen Drug Corp for the supply of Zolmitriptan 2.5 mg tablets in unit dose packages of 6, with a completion date of August 1, 2025. This competitively awarded, firm fixed-price contract reflects no set-aside designation and represents a routine pharmaceutical procurement supporting federal healthcare operations. The contract is executed at the vendor's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of Zolmitriptan 5 mg orally disintegrating tablets in unit dose packages of three, with a ceiling value of $4,829.14. The award was made on September 23, 2025, with an ultimate completion date of September 24, 2025, under a firm fixed-price arrangement with no set-aside designation. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for $2,597.90 on December 11, 2025, for the supply of Zolmitriptan 5 mg orally disintegrating tablets in unit dose packs of three. The contract was competitively awarded without set-aside provisions and is scheduled for completion by December 12, 2025, with performance taking place at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a relatively modest...
- SPE2DR25D3301Indefinite Delivery Contract
- SPE2DR25D3301-SPE2DR26F18VFDelivery Order
The Defense Logistics Agency awarded a $1,880.50 delivery order to AmerisourceBergen Drug Corp for Zolmitriptan 5 mg orally disintegrating tablets in unit dose packages of three on December 2, 2025. This non-set-aside, firm fixed-price contract is scheduled for completion by December 3, 2025, with performance at the awardee's corporate office in Conshohocken, Pennsylvania. Zolmitriptan is a triptan medication used in the treatment of migraine headaches, representing a critical pharmaceutical supply need for military and federal healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of medications, vaccines, and medical supplies to support military healthcare programs worldwide. AmerisourceBergen's extensive federal contract portfolio and competitive selection demonstrate its capability to fulfill federal procurement requirements, and the company continues to serve as a critical vendor for the Defense Health Agency and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9k | 12/1/25 |